117 related articles for article (PubMed ID: 28474044)
1. Glutathione binding to dirhodium tetraacetate: a spectroscopic, mass spectral and computational study of an anti-tumour compound.
Wong DL; Zhang A; Faponle AS; de Visser SP; Stillman MJ
Metallomics; 2017 May; 9(5):501-516. PubMed ID: 28474044
[TBL] [Abstract][Full Text] [Related]
2. Aerobic reactions of antitumor active dirhodium(II) tetraacetate Rh
Enriquez Garcia A; Jalilehvand F
J Biol Inorg Chem; 2018 Mar; 23(2):231-239. PubMed ID: 29214420
[TBL] [Abstract][Full Text] [Related]
3. Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (mu-carboxylato)dirhodium(II,II).
Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
J Am Chem Soc; 2003 Sep; 125(35):10703-13. PubMed ID: 12940756
[TBL] [Abstract][Full Text] [Related]
4. Binding of histidine and human serum albumin to dirhodium(II) tetraacetate.
Jalilehvand F; Enriquez Garcia A; Niksirat P; Finfrock YZ; Gelfand BS
J Inorg Biochem; 2021 Nov; 224():111556. PubMed ID: 34425475
[TBL] [Abstract][Full Text] [Related]
5. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of a fluorine-containing dirhodium tetracarboxylate compound with proteins.
Loreto D; Esposito A; Demitri N; Guaragna A; Merlino A
Dalton Trans; 2022 Mar; 51(9):3695-3705. PubMed ID: 35166290
[TBL] [Abstract][Full Text] [Related]
7. Digging into protein metalation differences triggered by fluorine containing-dirhodium tetracarboxylate analogues.
Loreto D; Esposito A; Demitri N; Guaragna A; Merlino A
Dalton Trans; 2022 May; 51(18):7294-7304. PubMed ID: 35482032
[TBL] [Abstract][Full Text] [Related]
8. Unusual Structural Features in the Adduct of Dirhodium Tetraacetate with Lysozyme.
Loreto D; Ferraro G; Merlino A
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540880
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head cross-linked adduct between the antitumor unit bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) and the DNA fragment d(GpG).
Chifotides HT; Dunbar KR
Chemistry; 2006 Aug; 12(25):6458-68. PubMed ID: 16900545
[TBL] [Abstract][Full Text] [Related]
10. Protein interactions of dirhodium tetraacetate: a structural study.
Ferraro G; Pratesi A; Messori L; Merlino A
Dalton Trans; 2020 Feb; 49(8):2412-2416. PubMed ID: 32022076
[TBL] [Abstract][Full Text] [Related]
11. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ
J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102
[TBL] [Abstract][Full Text] [Related]
12. Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh
Jalilehvand F; Enriquez Garcia A; Niksirat P
ACS Omega; 2017 Sep; 2(9):6174-6186. PubMed ID: 31457864
[TBL] [Abstract][Full Text] [Related]
13. Methionine Binding to Dirhodium(II) Tetraacetate.
Enriquez Garcia A; Jalilehvand F; Niksirat P; Gelfand BS
Inorg Chem; 2018 Oct; 57(20):12787-12799. PubMed ID: 30247895
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization, Absorption Properties, and Electronic Structures of Paddlewheel-Type Dirhodium(II) Tetra-μ-(
Kataoka Y; Fukumoto R; Yano N; Atarashi D; Tanaka H; Kawamoto T; Handa M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30691216
[TBL] [Abstract][Full Text] [Related]
15. Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione.
Shoeib T; Sharp BL
Metallomics; 2012 Dec; 4(12):1308-20. PubMed ID: 23128601
[TBL] [Abstract][Full Text] [Related]
16. Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: relevance to antitumour activity.
Hartinger CG; Casini A; Duhot C; Tsybin YO; Messori L; Dyson PJ
J Inorg Biochem; 2008 Dec; 102(12):2136-41. PubMed ID: 18834634
[TBL] [Abstract][Full Text] [Related]
17. Competition between glutathione and DNA oligonucleotides for ruthenium(II) arene anticancer complexes.
Wang F; Xu J; Wu K; Weidt SK; Mackay CL; Langridge-Smith PR; Sadler PJ
Dalton Trans; 2013 Mar; 42(9):3188-95. PubMed ID: 23076358
[TBL] [Abstract][Full Text] [Related]
18. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, DNA-binding and spectral properties of complexes [Ru(L)4(dppz)]2+ (L=Im and MeIm).
Chen LM; Liu J; Chen JC; Tan CP; Shi S; Zheng KC; Ji LN
J Inorg Biochem; 2008 Feb; 102(2):330-41. PubMed ID: 17981336
[TBL] [Abstract][Full Text] [Related]
20. Binding of DNA purine sites to dirhodium compounds probed by mass spectrometry.
Chifotides HT; Koomen JM; Kang M; Tichy SE; Dunbar KR; Russell DH
Inorg Chem; 2004 Oct; 43(20):6177-87. PubMed ID: 15446862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
